Loading your page…
5 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELAPRASE 2 mg/ml concentrate for solution for infusion | Idursulfase | Saudi Arabia | Authorised | |
| Empaveli 1080 mg per 20 ml | Pegcetacoplan | Saudi Arabia | Authorised | |
| Empaveli 1080 mg per 20 ml 8 vials | Pegcetacoplan | Saudi Arabia | Authorised | |
| REPLAGAL 1mg/ml concetrate for solution for infusion | Agalsidase alfa | Saudi Arabia | Authorised | |
| VPRIV 40 U POWDER FOR SOLUTION FOR INFUSION | Velaglucerase alfa | Saudi Arabia | Authorised | |
| ImmunoGam | Hepatitis b immunoglobulin | EU (EMA) | Withdrawn | 2010 |
| IXinity | Trenonacog alfa | EU (EMA) | Refused | |
| VARIZIG125 unit / vial · Kit | Varicella/zoster immunoglobulin | Canada | Cancelled | 2006 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 0 | 2 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
